Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy.
AUTOR(ES)
Ballantyne, C M
RESUMO
A multidisciplinary team approach with focused objectives characterizes research at Baylor College of Medicine into the causes, prevention, and treatment of atherosclerotic disease. Current clinical activities range from programs to modify lifestyle for the primary prevention of coronary artery disease to a large, angiographically monitored lipid-lowering trial. In basic research, much attention has been focused on the plasma lipoproteins and their roles in atherogenesis. The current review highlights recent advances in ongoing basic research involving 1) apolipoprotein (apo) B, whose form apo B-100 serves as a ligand for the low-density lipoprotein receptor; 2) lipoprotein[a], elevated plasma levels of which are predictive of atherosclerotic disease; and 3) transplantation arteriopathy, which impedes long-term survival of cardiac transplant recipients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=325131Documentos Relacionados
- IAIMS development at Baylor College of Medicine.
- Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
- Plexogenic arteriopathy.
- Endocardial lesion in a case of Takayasu's arteriopathy.
- Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
